SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

PL6 - Controversies in Neurology Plenary Session

Event Time: Thursday April 27, 2017 9:15 am to 11:30 am
Topic(s): Aging, Dementia, Cognitive, and Behavioral Neurology, Movement Disorders, MS and CNS Inflammatory Disease
Director(s):
Description: This session features experts discussing the most current and controversial issues in neuroscience. It is set up as a debate format in which two speakers argue one side of a single topic, followed by a rebuttal.
Completion Message:
CME Credits: 2.25
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
9:15 AM - 10:00 AM Yes: Is Focused Ultrasound Better Than Deep Brain Stimulation? Paul Fishman MD, PhD 
9:15 AM - 10:00 AM No: Is Focused Ultrasound Better Than Deep Brain Stimulation? Michael Okun MD, FAAN 
10:00 AM - 10:45 AM Yes: Should Disease-modifying Therapies Be Stopped in Progressive MS? John Corboy MD, FAAN 
10:00 AM - 10:45 AM No: Should Disease-modifying Therapies Be Stopped in Progressive MS? Robert Naismith MD 
10:45 AM - 11:30 AM No: Does Removal of Amyloid Improve Cognition in Alzheimer's Disease? George Perry PhD 
10:45 AM - 11:30 AM Yes: Does Removal of Amyloid Improve Cognition in Alzheimer's Disease? Reisa Sperling MD 

Disclosures

Speaker Disclosure
John Corboy, MD, FAAN Dr. Corboy has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Prime CME. Dr. Corboy has received personal compensation in an editorial capacity for American Academy of Neurology. Dr. Corboy has received research support from Med Day, Novartis, Biogen.

Paul S. Fishman, MD, PhD Receives personal compensation for activities with Insightec . . . . . Focused Ultrasound Surgery Foundation and the Department of Veterans Affairs

Robert T. Naismith, MD Dr. Naismith has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acorda, Alkermes, Bayer, Biogen, EMD Serono, Genentech, Genzyme, Novartis, Teva.. Dr. Naismith has received personal compensation in an editorial capacity for NEJM Journal Watch.

Michael S. Okun, MD, FAAN Dr. Okun has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with National Parkinson Foundation, Medscape, Mededicus. Dr. Okun has received personal compensation in an editorial capacity for New England Journal of Medicine Journal Watch, JAMA Neurology.

George Perry, PhD Dr. Perry has nothing to disclose.

Reisa A. Sperling, MD R. Sperling has served as a paid consultant for Abbvie, Biogen, Bracket, Genentech, Lundbeck, Merck, Pfizer, Roche, and Sanofi. She has served as an Investigator for Avid, Eli Lilly, and Janssen clinical trials. She has spoken at symposia sponsored by Eli Lilly, Biogen, and Janssen. R. Sperling receives research support from Janssen Pharmaceuticals, and Eli Lilly and Co. These relationships are not related to the content in the manuscript. She also receives research support from the the National Institute on Aging, Fidelity Biosciences, Harvard NeuroDiscovery Center, and the Alzheimer’s Association.

Register Now

Related Courses

Sunday April 22, 2018

7:00 AM-9:00 AM
C24 Hot Topics and Controversies in Parkinson's Disease Melissa Nirenberg MD, PhD, FAAN
C32 Clinicopathological Correlation Session in Dementia David Irwin MD
C33 Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making Aaron Miller MD, FAAN
1:00 PM-3:00 PM
C36 Nonmotor Manifestations of Parkinson's Disease I Charles Adler MD, PhD, FAAN
3:30 PM-5:30 PM
C50 Nonmotor Manifestations of Parkinson's Disease II Charles Adler MD, PhD, FAAN
C57 Spanish: Update on MS Therapy Lilyana Amezcua MD

Wednesday April 25, 2018

7:00 AM-9:00 AM
C139 Paroxysmal Movement Disorders Kailash Bhatia MD, FAAN
C134 Neurocognitive Assessment for Neurologists Mario Mendez MD, PhD, FAAN
C135 Multiple Sclerosis Therapy: Disease-modifying Treatment I David Jones MD
C132 Higher Cortical Visual Disorders: Case-based Review Sashank Prasad MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C144 Severe TBI: From ICU to Rehabilitation Susanne Muehlschlegel MD,MPH
C145 Non-Alzheimer's Dementia I: Frontotemporal Dementias Gil Rabinovici MD
C146 Multiple Sclerosis Therapy: Disease-modifying Treatment II John Rose MD, FAAN
1:00 PM-5:30 PM
C158 Clinical Uses of Botulinum Toxin for Dystonia Skills Workshop Diego Torres-Russotto MD, FAAN
3:30 PM-5:30 PM
C160 Non-Alzheimer's Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias Gil Rabinovici MD
C161 Multiple Sclerosis Therapy: Symptom Management Jonathan Carter MD

MEMBER LOG IN

Forgot Password?